Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling Protocol Deviations and Violations

Posted on By

Standard Operating Procedure for Managing Protocol Deviations and Violations

Purpose

This SOP outlines the procedures for identifying, documenting, and managing protocol deviations and violations in clinical trials and clinical studies. The goal is to ensure the integrity of the study and the safety of participants by promptly addressing and reporting deviations and violations.

Scope

This SOP applies to all personnel involved in clinical trials and clinical studies, including principal investigators, clinical research coordinators, study sponsors, and data management teams.

Responsibilities

  • Principal Investigator (PI): Oversees the management of protocol deviations and violations, ensuring appropriate reporting and corrective actions.
  • Clinical Research Coordinators: Monitor study conduct to identify and report deviations and violations at the site level.
  • Data Management Team: Assists with the documentation and reporting of deviations and violations in study data.
  • Study Sponsors: Provide resources and support for the management of protocol deviations and violations.
See also  SOP for Blinding and Masking

Procedure

  • Identification of Deviations and Violations:
    • Monitor study activities to identify protocol deviations and violations as they occur.
    • Review study data and documentation regularly to detect deviations and violations.
  • Classification and Documentation:
    • Classify each incident as a deviation or violation based on the study protocol and guidelines.
    • Document each deviation or violation in a deviation log or record, including details such as the date, nature of the incident, and impact on the
study.
  • Reporting:
    • Report protocol deviations and violations to the appropriate parties (e.g., study sponsor, IRB/IEC) as required by regulatory guidelines and the study protocol.
    • Ensure timely reporting of serious violations that may impact participant safety or data integrity.
  • Investigation and Root Cause Analysis:
    • Investigate each deviation or violation to determine the root cause and potential impact on the study.
    • Document the findings and proposed corrective actions.
  • Corrective and Preventive Actions:
    • Implement corrective actions to address the immediate issue and prevent recurrence.
    • Review study procedures and training materials to minimize future deviations and violations.
  • Follow-Up and Monitoring:
    • Monitor the effectiveness of corrective and preventive actions over time.
    • Conduct follow-up assessments to ensure compliance and identify any further areas for improvement.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator
    • IRB/IEC: Institutional Review Board/Independent Ethics Committee

    Documents

    • Protocol deviation and violation logs
    • Investigation and root cause analysis reports
    • Corrective and preventive action plans
    • Follow-up monitoring reports

    References

    • Institutional policies for handling protocol deviations and violations
    • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)
    • Study protocols and investigator brochures

    SOP Version

    Version: 1.0

    See also  SOP for Monitoring and Auditing
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Blinding and Masking
    Next Post: SOP for Statistical Analysis and Data Interpretation

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version